You just read:

DelMar Pharmaceuticals Presents Overview of VAL-083's Unique Anticancer Mechanism at the European Association of Neuro-Oncology (EANO) Annual Meeting

News provided by

DelMar Pharmaceuticals, Inc.

17 Oct, 2016, 08:30 ET